Remdesivir for the Treatment of COVID-19: A Systematic Review of the Literature
In March 2020, the World Health Organization declared the spread of SARS-CoV-2 a global pandemic. To date, coronavirus disease-2019 (COVID-19) has spread to over 200 countries, leading to over 1.6 million cases and over 99,000 deaths. Given that there is neither a vaccine nor proven treatment for CO...
Main Authors: | Arif Musa, Kasim Pendi, Areio Hashemi, Elizabeth Warbasse, Sarkis Kouyoumjian, Jenna Yousif, Emily Blodget, Susan Stevens, Besma Aly, David A. Baron |
---|---|
Format: | Article |
Language: | English |
Published: |
eScholarship Publishing, University of California
2020-07-01
|
Series: | Western Journal of Emergency Medicine |
Online Access: | https://escholarship.org/uc/item/9z6961f2 |
Similar Items
-
Addendum to Systematic Review of Remdesivir for the Treatment of COVID-19
by: Arif Musa, et al.
Published: (2020-07-01) -
Is There Enough Evidence to Avoid Remdesivir Use in Patients with Severe Renal Impairment? A Review of the Pharmacological and Clinical Literature
by: Suresh J. ANTONY, et al.
Published: (2021-12-01) -
Remdesivir as a potential antiviral agent for COVID-19: A literature review
by: Susanna Josey
Published: (2020-01-01) -
Therapeutic Efficacy and Outcomes of Remdesivir versus Remdesivir with Tocilizumab in Severe SARS-CoV-2 Infection
by: Damiana-Maria Vulturar, et al.
Published: (2022-11-01) -
A novel simulation model for tube thoracostomy
by: Sarkis Kouyoumjian, et al.
Published: (2023-06-01)